Alnylam to Webcast Presentations at Upcoming June Investor Conferences
Jefferies 2019 Global Healthcare Conference on
Friday, June 7, 2019at 10:30 am ETin New York City Goldman Sachs40th Annual Global Healthcare Conference on Wednesday, June 12, 2019at 2:40 pm PT( 5:40 pm ET) at the Terranea Resortin Rancho Palos Verdes, California
A live audio webcast of each presentation will be available on the Investors section of the Company’s website, www.alnylam.com. A replay will be available on the Alnylam website within 48 hours after each event.
Alnylam (Nasdaq: ALNY) is leading the translation of RNA interference
(RNAi) into a new class of innovative medicines with the potential to
transform the lives of people afflicted with rare genetic,
cardio-metabolic, hepatic infectious, and central nervous system/ocular
diseases. Based on Nobel Prize-winning science, RNAi therapeutics
represent a powerful, clinically validated approach for the treatment of
diseases with high unmet need. ONPATTRO® (patisiran) is the
first-ever RNAi therapeutic approved by the U.S.
Alnylam Pharmaceuticals, Inc.
Christine Regan Lindenboom
(Investors and Media)